Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program

Fig. 5

CT/PET-CT scans from a patient with metastatic Merkel cell carcinoma treated with avelumab. a Progressive disease at baseline (January 2017), b CR at 20 months after starting avelumab treatment (September 2018), and c CR in June 2020. Images were provided by Dr. Ciliberto. CR complete response, PET-CT positron emission tomography–computed tomography

Back to article page